Literature DB >> 28569250

Interleukin 8 in progression of hormone-dependent early breast cancer.

Jelena Milovanovic1, Natasa Todorovic-Rakovic, Tijana Vujasinovic, Zaki Abu Rabi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28569250     DOI： 10.1007/s12038-017-9679-4

Source DB:  PubMed          Journal:  J Biosci        ISSN： 0250-5991            Impact factor:   1.826


× No keyword cloud information.
  29 in total

Review 1.  Interleukin-8 and human cancer biology.

Authors:  K Xie
Journal:  Cytokine Growth Factor Rev       Date:  2001-12       Impact factor: 7.638

2.  Interleukin-8, a promising predictor for prognosis of pancreatic cancer.

Authors:  Ying Chen; Min Shi; Guan-Zhen Yu; Xiao-Ran Qin; Gang Jin; Peng Chen; Ming-Hua Zhu
Journal:  World J Gastroenterol       Date:  2012-03-14       Impact factor: 5.742

3.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

4.  Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients.

Authors:  L Kozłowski; I Zakrzewska; P Tokajuk; M Z Wojtukiewicz
Journal:  Rocz Akad Med Bialymst       Date:  2003

5.  Estrogen receptor levels and survival of breast cancer patients. A study on patients participating in randomized trials of adjuvant therapy.

Authors:  L Skoog; S Humla; M Axelsson; M Frost; A Norman; B Nordenskjöld; A Wallgren
Journal:  Acta Oncol       Date:  1987       Impact factor: 4.089

Review 6.  Interleukin-8 in breast cancer progression.

Authors:  Nataša Todorović-Raković; Jelena Milovanović
Journal:  J Interferon Cytokine Res       Date:  2013-05-22       Impact factor: 2.607

7.  IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells.

Authors:  Ariane Freund; Corine Chauveau; Jean-Paul Brouillet; Annick Lucas; Matthieu Lacroix; Anne Licznar; Françoise Vignon; Gwendal Lazennec
Journal:  Oncogene       Date:  2003-01-16       Impact factor: 9.867

8.  Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients.

Authors:  Lisa K Dunnwald; Mary Anne Rossing; Christopher I Li
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

9.  Interleukin-8 modulates growth and invasiveness of estrogen receptor-negative breast cancer cells.

Authors:  Chen Yao; Ying Lin; Mei-Sze Chua; Cai-Sheng Ye; Jiong Bi; Wen Li; Yi-Fan Zhu; Shen-Ming Wang
Journal:  Int J Cancer       Date:  2007-11-01       Impact factor: 7.396

Review 10.  Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells.

Authors:  Jagdeep K Singh; Bruno M Simões; Sacha J Howell; Gillian Farnie; Robert B Clarke
Journal:  Breast Cancer Res       Date:  2013       Impact factor: 6.466
View more
  2 in total

1.  Heregulin Drives Endocrine Resistance by Altering IL-8 Expression in ER-Positive Breast Cancer.

Authors:  Adriana Papadimitropoulou; Luciano Vellon; Ella Atlas; Travis Vander Steen; Elisabet Cuyàs; Sara Verdura; Ingrid Espinoza; Javier A Menendez; Ruth Lupu
Journal:  Int J Mol Sci       Date:  2020-10-19       Impact factor: 5.923

2.  Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer.

Authors:  Ho Tsoi; Ling Shi; Man-Hong Leung; Ellen P S Man; Zi-Qing So; Wing-Lok Chan; Ui-Soon Khoo
Journal:  Life (Basel)       Date:  2022-01-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.